Can coffee interact with medications?

Yes, coffee has several documented and clinically significant drug interactions. The most important concern thyroid medications (levothyroxine — reduced absorption if taken simultaneously), iron supplements (absorption reduction of 39 to 90 % depending on studies), certain antibiotics (quinolones like ciprofloxacin — CYP1A2 inhibition that slows caffeine elimination), MAOI antidepressants, and certain anticoagulants. These interactions are manageable through simple timing adjustments in most cases.

Interactions between coffee and medications operate through several distinct mechanisms that are useful to understand separately, allowing informed adjustments to consumption habits.

The first mechanism is reduced absorption through chelation. Coffee polyphenols — particularly tannins and chlorogenic acids — form insoluble complexes with certain minerals and molecules during intestinal transit. The best-documented case is non-haem iron (plant-sourced iron): a classic study by Morck et al. (1983) showed that a cup of coffee taken simultaneously with a meal containing plant iron reduced iron absorption by 39 %; other studies with strong coffee or taken immediately after an iron supplement measured reductions of up to 90 %. This interaction is particularly important for people on iron supplementation or treating iron-deficiency anaemia. The practical recommendation is simple: allow at least 1 hour (ideally 2 hours) between iron intake and coffee or tea consumption.

The second mechanism is absorption competition. Levothyroxine (Euthyrox, L-Thyrox, Synthroid) is a thyroid replacement medication taken on an empty stomach in the morning. Studies have shown that consuming coffee — even black — within 30 to 60 minutes of taking it significantly reduces levothyroxine bioavailability, potentially requiring dose increases. The standard recommendation is to wait at least 30 to 60 minutes after levothyroxine before drinking coffee, and some endocrinologists recommend 60 to 90 minutes for patients with unstable TSH levels.

The third mechanism is CYP1A2 enzymatic inhibition. Caffeine is metabolised by CYP1A2, and several medications inhibit this enzyme, extending caffeine's half-life and potentially amplifying its adverse effects. Key CYP1A2 inhibitors include fluvoxamine (SSRI antidepressant), ciprofloxacin and enoxacin (quinolone antibiotics), zileuton (antiasthmatic) and verapamil (antiarrhythmic). A patient on ciprofloxacin who continues normal coffee consumption may experience doubled or tripled caffeine half-life, leading to insomnia, palpitations and anxiety even at usual coffee doses.

The fourth mechanism concerns MAOIs (monoamine oxidase inhibitors). These increasingly rare antidepressants interact with tyramine (present in some coffees) and caffeine itself, potentially triggering hypertensive crises. Patients on MAOIs must strictly limit caffeine intake and avoid specialty coffees rich in free amino acids.

Finally, coffee can modify the effect of coumarin-type anticoagulants (warfarin, acenocoumarol) through several pathways: polyphenols have mild antiplatelet properties, and certain variations in warfarin metabolism via CYP2C9 may be indirectly affected. These interactions are generally small in magnitude at moderate consumption, but should be monitored in patients with unstable INR.

The general rule is simple: when in doubt about an interaction, consult your doctor or pharmacist, and adopt a 'timing offset' rule — consume coffee 1 to 2 hours after sensitive medications, not simultaneously.

Key coffee–medication interactions